エピソード

  • Ep. 129: From then to now: Neurology through the years
    2025/01/05

    EAN moderator: Thomas Berger (Vienna, Austria)

    Guest: Gereon Fink (Cologne, Germany)

    In this first eanCast episode of 2025, Thomas Berger and Gereon Fink discuss how dramatically Neurology has changed due to fundamental breakthroughs in understanding the pathophysiology and pathomechanisms of neurological disorders, enabling the development of specific novel treatments, eventually resulting in personalized approaches. Thomas Berger and Gereon Fink reflect upon how methodological advances have catalyzed this progress and how an exact understanding of disease pathology also informs the prevention of neurological diseases, opening avenues for a new era of neurology.

    続きを読む 一部表示
    33 分
  • Ep. 128: Inclusive Communication with sexual and gender minorities in Neurology
    2024/12/29

    Moderator: Francesco Pasini (Milano, Italy)

    Cianán Russell (Brussels, Belgium)

    In this last episode of the year, Francesco Pasini and Cianán Russel talk about inclusive communication with sexual and gender minorities in Neurology. The topics discussed include the stigma experienced by the LGBTI population in healthcare, some suggestions for inclusive communication with patients, and reflections on the need to explore new languages and approaches for diverse patient populations.

    eanCast Listener Feedback Survey: https://www.surveymonkey.com/r/eanCast

    続きを読む 一部表示
    22 分
  • Ep. 127: Sex and gender differences in Parkinson’s disease
    2024/12/22

    Moderator: Vanessa Carvalho (Lisbon, Portugal)

    Guest: Angelo Antonini (Padua, Italy)

    This week Vanessa Carvalho hosts expert Angelo Antonini as they review not only prevalence but also sex and gender differences in response to treatment, and the treatment of specific populations such as pregnant women. They also approach the bias in enrollment of women living with PD in clinical trials, its main causes and the main consequences of this underrepresentation. Please find suggested further reading on this episode here: Further Reading on eanCast Episodes - ean.org

    eanCast Listener Feedback Survey: https://www.surveymonkey.com/r/eanCast

    続きを読む 一部表示
    27 分
  • Ep. 126: Sex and gender differences in Alzheimer’s disease
    2024/12/15

    Moderator: Luca Cuffaro (Milano, Italy)

    Guest: Julie Novakova Martinkova (Prague, Czechia)

    In this episode, Dr. Luca Cuffaro and Dr. Julie Novakova Martinkova discuss sex and gender differences in Alzheimer's disease. Topics discussed include differences in Alzheimer's disease epidemiology, progression, biomarkers, clinical trials, and prospective treatments, with a special focus on their potential biological mechanisms. Please find suggested further reading on this episode here: Further Reading on eanCast Episodes - ean.org

    eanCast Listener Feedback Survey: https://www.surveymonkey.com/r/eanCast

    続きを読む 一部表示
    25 分
  • Ep. 125: Navigating Gender Differences in Neurology Careers
    2024/12/08

    Moderator: Alice Accorroni (Geneva, Switzerland)

    Guest: Marianne de Visser (Amsterdam, Netherlands)

    In this week’s episode Alice Accorroni and Marianne de Visser discuss the multifaceted impact of gender on career trajectories in neurology, examining mentorship dynamics and the intersectionality of gender with ethnicity and socioeconomic background. They discuss the importance of support networks, education, and fostering a gender-sensitive culture. Highlighting the value of representation in leadership, they share insights and practical solutions to promote diversity, inclusion, and acceptance.

    eanCast Listener Feedback Survey: https://www.surveymonkey.com/r/eanCast

    続きを読む 一部表示
    24 分
  • Ep. 124: Insights into the EAN Leadership Programme
    2024/12/01

    Ean Moderator: Anja Sander (Vienna, Austria)

    Guest: Peter Dedeken (Sint-Katelijne-Waver, Belgium)

    Guest: Vanessa Carvalho (Lisbon, Portugal)

    This week we are happy to share an episode about the EAN Leadership Programme. EAN Executive Director, Anja Sander, hosts two participants of the current round of the Leadership Programme: Peter Dedeken and Vanessa Carvalho. They share their motivation, learnings and benefits of participating in the programme, not only for leading others, buts also for leading themselves. The application for the next round of the Leadership Programme opens on 2 December 2024 - please find all information about the application procedure here: EAN Leadership Programme - ean.org

    For more insights into the programme, see this article from another participant, Raphael Wurm: Why I applied for the EAN Leadership Programme and what I have learned - eanpages
    The link to the mentioned burnout study can be found here: Education Research: Impact of Burnout on Neurology Residents and Research Fellows in Europe | Neurology Education

    eanCast Listener Feedback Survey: https://www.surveymonkey.com/r/eanCast

    続きを読む 一部表示
    25 分
  • Ep. 123: News on the risk of malformations and developmental impairment among the offspring of male patients under antiseizure medication​
    2024/11/24

    Moderator: Bernhard J. Steinhoff (Kehl-Kork, Germany)

    Guest: Jakob Christensen (Aarhus, Denmark)

    In this last November episode Bernhard Steinhoff and Jakob Christensen give an update on new data concerning the risk of the offspring of male patients under antiseizure medications. They discuss that the warnings of the EMA about autism spectrum disorders and cognitive impairment that raised major concern now appear less intimidating due to recently published results from a huge Scandinavian registry study.

    続きを読む 一部表示
    17 分
  • Ep. 122: News on the risk of malformations and developmental impairment among the offspring of female patients under antiseizure medication
    2024/11/17

    Moderator: Bernhard J. Steinhoff (Kehl-Kork, Germany)

    Guest: Jakob Christensen (Aarhus, Denmark)

    This week Bernhard Steinhoff talks with Jakob Christensen about the latest news on the risk of antiseizure medications in pregnancy and beyond. They mention new data on teratogenicity and the increased probability of autism spectrum disorders and cognitive impairment of the offspring.

    続きを読む 一部表示
    18 分